Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurosci
    August 2022
  1. MUMFORD P, Tosh J, Anderle S, Gkanatsiou Wikberg E, et al
    Genetic Mapping of APP and Amyloid-beta Biology Modulation by Trisomy 21.
    J Neurosci. 2022;42:6453-6468.
    >> Share

  2. GUO T, Pan X, Jiang G, Zhang D, et al
    Downregulating PTBP1 fails to convert astrocytes into hippocampal neurons and to alleviate symptoms in Alzheimer's mouse models.
    J Neurosci. 2022 Aug 9. pii: JNEUROSCI.1060-22.2022.
    >> Share

  3. WALSH C, Ridler T, Margetts-Smith G, Garcia Garrido M, et al
    Beta bursting in the retrosplenial cortex is a neurophysiological correlate of environmental novelty which is disrupted in a mouse model of Alzheimer's disease.
    J Neurosci. 2022 Aug 4. pii: JNEUROSCI.0890-21.2022.
    >> Share

  4. BAIER MP, Nagaraja RY, Yarbrough HP, Owen DB, et al
    Selective Ablation of Sod2 in Astrocytes Induces Sex-Specific Effects on Cognitive Function, d-Serine Availability, and Astrogliosis.
    J Neurosci. 2022;42:5992-6006.
    >> Share

  5. CAI C, Wang L, Li S, Lou S, et al
    Ras Inhibitor Lonafarnib Rescues Structural and Functional Impairments of Synapses of Abeta1-42 Mice via alpha7nAChR-Dependent BDNF Upregulation.
    J Neurosci. 2022;42:6090-6107.
    >> Share

    July 2022
  6. WANG S, Fu Y, Miyata T, Matsumoto S, et al
    Functional cooperation of alpha-synuclein and tau is essential for proper corticogenesis.
    J Neurosci. 2022 Jul 29. pii: JNEUROSCI.0396-22.2022.
    >> Share

  7. BOLD CS, Baltissen D, Ludewig S, Back MK, et al
    APPsalpha Rescues Tau-Induced Synaptic Pathology.
    J Neurosci. 2022;42:5782-5802.
    >> Share

    June 2022
  8. WANG LH, Lin CY, Lin YM, Buee L, et al
    Calpain-2 Mediates MBNL2 Degradation and a Developmental RNA Processing Program in Neurodegeneration.
    J Neurosci. 2022;42:5102-5114.
    >> Share

  9. SHI Q, Chang C, Saliba A, Bhat MA, et al
    Microglial mTOR Activation Upregulates Trem2 and Enhances beta-Amyloid Plaque Clearance in the 5XFAD Alzheimer's Disease Model.
    J Neurosci. 2022 Jun 2. pii: JNEUROSCI.2427-21.2022.
    >> Share

    May 2022

  10. Erratum: Larson et al., "Soluble alpha-Synuclein Is a Novel Modulator of Alzheimer's Disease Pathophysiology".
    J Neurosci. 2022 May 26. pii: JNEUROSCI.0896-22.2022.
    >> Share

  11. TU G, Halawa A, Yu X, Gillman S, et al
    Outcome-Locked Cholinergic Signaling Suppresses Prefrontal Encoding of Stimulus Associations.
    J Neurosci. 2022;42:4202-4214.
    >> Share

    April 2022
  12. DE OLIVEIRA P, Cella C, Locker N, Ravindran KKG, et al
    Improved Sleep, Memory, and Cellular Pathological Features of Tauopathy, Including the NLRP3 Inflammasome, after Chronic Administration of Trazodone in rTg4510 Mice.
    J Neurosci. 2022;42:3494-3509.
    >> Share

    January 2022

  13. Erratum: Takamura et al., "Modality-Specific Impairment of Hippocampal CA1 Neurons of Alzheimer's Disease Model Mice".
    J Neurosci. 2022 Jan 27. pii: JNEUROSCI.2522-21.2021.
    >> Share

  14. DE FLORES R, Das SR, Xie L, Wisse LEM, et al
    Medial temporal lobe networks in Alzheimer's disease: structural and molecular vulnerabilities.
    J Neurosci. 2022 Jan 26. pii: JNEUROSCI.0949-21.2021.
    >> Share

  15. KOCAGONCU E, Nesbitt D, Emery T, Hughes L, et al
    Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease.
    J Neurosci. 2022 Jan 10. pii: JNEUROSCI.0697-21.2021.
    >> Share

  16. ISLAM S, Sun Y, Gao Y, Nakamura T, et al
    Presenilin is essential for ApoE secretion, a novel role of presenilin involved in Alzheimer's disease pathogenesis.
    J Neurosci. 2022 Jan 5. pii: JNEUROSCI.2039-21.2021.
    >> Share

    December 2021

  17. Expression of Concern: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2306-21.2021.
    >> Share


  18. Expression of Concern: Wang et al., "Dissociating beta-Amyloid from alpha7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes alpha7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain".
    J Neurosci. 2021 Dec 17. pii: JNEUROSCI.2307-21.2021.
    >> Share

  19. CUI J, Ait-Ghezala G, Sambamurti K, Gao F, et al
    Sex-specific regulation of beta-Secretase: a novel estrogen response element (ERE)-dependent mechanism in Alzheimer's disease.
    J Neurosci. 2021 Dec 9. pii: JNEUROSCI.0864-20.2021.
    >> Share

  20. CHAVES RS, Tran M, Holder AR, Balcer AM, et al
    Amyloidogenic Processing of Amyloid Precursor Protein Drives Stretch-Induced Disruption of Axonal Transport in hiPSC-Derived Neurons.
    J Neurosci. 2021;41:10034-10053.
    >> Share

    November 2021

  21. Erratum: Medeiros et al., "Connecting TNF-alpha Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid beta Protein".
    J Neurosci. 2021 Nov 17. pii: JNEUROSCI.2000-21.2021.
    >> Share


  22. Erratum: Wang et al., "Reducing Amyloid-Related Alzheimer's Disease Pathogenesis by a Small Molecule Targeting Filamin A".
    J Neurosci. 2021 Nov 10. pii: JNEUROSCI.2154-21.2021.
    >> Share

    August 2021
  23. WU M, Liu CZ, Barrall EA, Rissman RA, et al
    Unbalanced regulation of alpha7 nAChRs by Ly6h and NACHO contributes to neurotoxicity in Alzheimer's disease.
    J Neurosci. 2021 Aug 26. pii: JNEUROSCI.0494-21.2021.
    >> Share

    May 2021
  24. OAKLEY DH, Klickstein N, Commins C, Chung M, et al
    Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.
    J Neurosci. 2021;41:4335-4348.
    >> Share

  25. SALAMONE PC, Legaz A, Sedeno L, Moguilner S, et al
    Interoception Primes Emotional Processing: Multimodal Evidence from Neurodegeneration.
    J Neurosci. 2021;41:4276-4292.
    >> Share

  26. TAKAMURA R, Mizuta K, Sekine Y, Islam T, et al
    Modality specific impairment of hippocampal CA1 neurons of Alzheimer's disease model mice.
    J Neurosci. 2021 May 10. pii: JNEUROSCI.0208-21.2021.
    >> Share

  27. GOODMAN AM, Langner BM, Jackson N, Alex C, et al
    Heightened hippocampal beta-adrenergic receptor function drives synaptic potentiation and supports learning and memory in the TgF344-AD rat model during prodromal Alzheimer's disease.
    J Neurosci. 2021 May 5. pii: JNEUROSCI.0119-21.2021.
    >> Share

    April 2021
  28. ADAMS JN, Maass A, Berron D, Harrison TM, et al
    Reduced Repetition Suppression in Aging is Driven by Tau-Related Hyperactivity in Medial Temporal Lobe.
    J Neurosci. 2021;41:3917-3931.
    >> Share

  29. VAN SKIKE CE, Hussong SA, Hernandez SF, Banh AQ, et al
    mTOR attenuation with rapamycin reverses neurovascular uncoupling and memory deficits in mice modeling Alzheimer's disease.
    J Neurosci. 2021 Apr 20. pii: JNEUROSCI.2144-20.2021.
    >> Share

    March 2021
  30. MORENO-JIMENEZ EP, Terreros-Roncal J, Flor-Garcia M, Rabano A, et al
    Evidences for Adult Hippocampal Neurogenesis in Humans.
    J Neurosci. 2021;41:2541-2553.
    >> Share

    February 2021
  31. SANCHEZ-AGUILERA A, Quintanilla JP
    Sharp Wave Ripples in Alzheimer's Disease: In Search of Mechanisms.
    J Neurosci. 2021;41:1366-1370.
    >> Share

  32. RIVERS-AUTY J, Tapia VS, White CS, Daniels MJ, et al
    Zinc status alters Alzheimer's disease progression through NLRP3-dependent inflammation.
    J Neurosci. 2021 Feb 16. pii: JNEUROSCI.1980-20.2020.
    >> Share

    November 2020
  33. FRACASSI A, Marcatti M, Zolochevska O, Tabor N, et al
    Oxidative damage and antioxidant response in frontal cortex of demented and non-demented individuals with Alzheimer's neuropathology.
    J Neurosci. 2020 Nov 24. pii: JNEUROSCI.0295-20.2020.
    >> Share

    October 2020
  34. ALBRECHT D, Isenberg AL, Stradford J, Monreal T, et al
    Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid.
    J Neurosci. 2020;40:8573-8586.
    >> Share


  35. Erratum: Forny-Germano et al., "Alzheimer's Disease-Like Pathology Induced by Amyloid-beta Oligomers in Nonhuman Primates".
    J Neurosci. 2020 Oct 6. pii: JNEUROSCI.1827-20.2020.
    >> Share

    September 2020
  36. CHEN W, Wang M, Zhu M, Xiong W, et al
    14,15-epoxyeicosatrienoic acid alleviates pathology in a mouse model of Alzheimer's disease.
    J Neurosci. 2020 Sep 24. pii: JNEUROSCI.1246-20.2020.
    >> Share

  37. ZHANG H, Lin A, Gong P, Chen Y, et al
    The Chemokine-like Receptor 1 Deficiency Improves Cognitive Deficits of AD Mice and Attenuates Tau Hyperphosphorylation via Regulating Tau Seeding.
    J Neurosci. 2020;40:6991-7007.
    >> Share

    August 2020
  38. GHALAYINI J
    Exploring the Therapeutic Potential of Protein Tyrosine Phosphatase 1B in hAPP-J20 Mouse Model of Alzheimer's Disease.
    J Neurosci. 2020;40:6100-6102.
    >> Share

    July 2020
  39. ZHANG H, Chen W, Tan Z, Zhang L, et al
    A Role of Low-Density Lipoprotein Receptor-Related Protein 4 (LRP4) in Astrocytic Abeta Clearance.
    J Neurosci. 2020;40:5347-5361.
    >> Share

    May 2020
  40. SHEYNIN Y, Rosa-Neto P, Hess RF, Vaucher E, et al
    Cholinergic modulation of binocular vision.
    J Neurosci. 2020 May 25. pii: JNEUROSCI.2484-19.2020.
    >> Share

  41. CACCAVANO A, Bozzelli PL, Forcelli PA, Pak DTS, et al
    Inhibitory parvalbumin basket cell activity is selectively reduced during hippocampal sharp wave ripples in a mouse model of familial Alzheimer's disease.
    J Neurosci. 2020 May 21. pii: JNEUROSCI.0425-20.2020.
    >> Share

    April 2020
  42. SHIMOJO M, Takuwa H, Takado Y, Tokunaga M, et al
    Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
    J Neurosci. 2020;40:3491-3501.
    >> Share

    February 2020
  43. ONUSKA KM
    The Dual Role of Microglia in the Progression of Alzheimer's Disease.
    J Neurosci. 2020;40:1608-1610.
    >> Share

    January 2020
  44. MEILANDT WJ, Ngu H, Gogineni A, Lalehzadeh G, et al
    Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Abeta42:Abeta40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's mouse model.
    J Neurosci. 2020 Jan 24. pii: JNEUROSCI.1871-19.2019.
    >> Share

  45. SCHMITZ TW, Soreq H, Poirier J, Spreng RN, et al
    Longitudinal basal forebrain degeneration interacts with TREM2/C3 biomarkers of inflammation in pre-symptomatic Alzheimer's disease.
    J Neurosci. 2020 Jan 8. pii: JNEUROSCI.1184-19.2019.
    >> Share

  46. RICKE KM, Cruz SA, Qin Z, Farrokhi K, et al
    Neuronal Protein Tyrosine Phosphatase 1B hastens Amyloid beta-associated Alzheimer's disease in mice.
    J Neurosci. 2020 Jan 8. pii: JNEUROSCI.2120-19.2019.
    >> Share

    December 2019
  47. FAN Q, He W, Gayen M, Robert Benoit M, et al
    Activated CX3CL1/Smad2 signals prevent neuronal loss and Alzheimer's tau pathology-mediated cognitive dysfunction.
    J Neurosci. 2019 Dec 10. pii: JNEUROSCI.1333-19.2019.
    >> Share

  48. CHENG A, Wang J, Ghena N, Zhao Q, et al
    SIRT3 Haploinsufficiency Aggravates Loss of GABAergic Interneurons and Neuronal Network Hyperexcitability in an Alzheimer's Disease Model.
    J Neurosci. 2019 Dec 9. pii: JNEUROSCI.1446-19.2019.
    >> Share

    October 2019
  49. LEI M, Teo JD, Song H, McEwen HP, et al
    Sphingosine kinase 2 potentiates amyloid deposition but protects against hippocampal volume loss and demyelination in a mouse model of Alzheimer's disease.
    J Neurosci. 2019 Oct 21. pii: JNEUROSCI.0524-19.2019.
    >> Share

    September 2019
  50. SINGH A, Jones OD, Mockett BG, Ohline SM, et al
    Tumor Necrosis Factor-alpha-Mediated Metaplastic Inhibition of LTP is Constitutively Engaged in an Alzheimer's Disease Model.
    J Neurosci. 2019 Sep 30. pii: JNEUROSCI.1492-19.2019.
    >> Share

    January 2019
  51. HUIJBERS W, Schultz AP, Papp KV, LaPoint MR, et al
    Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity.
    J Neurosci. 2019;39:548-556.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016